Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Lumos Diagnostics Holdings Limited, a healthcare technology firm, has announced its application for the quotation of 182,774,246 ordinary fully paid securities on the ASX under the code LDX. The announcement, dated October 09, 2024, signifies the company’s next step in expanding its investor base and enhancing its financial visibility.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.